Saturday, December 08, 2012

December 7, 2012: NECC Tainted Steroid Medication Update

Our firm filed a Motion to Inspect the NECC facility. The FDA issued an inspection report, and in it there are observations of the New England Compounding Facility. A number of issues will be part of the litigation, including the "Clean Room" where the recalled products were made.  

Here's a virtual clean room, put together by Purdue:

Generally found in hospitals and home health care companies, the rooms are used to prepare drugs, intravenous drips, syringes, chemotherapy treatments and the like, especially those administered directly into the bloodstream—a factor that makes vital the use of a clean room and proper clean-room procedures. Concern over the rise of antibiotic-resistant pathogens has only increased the need for such expertise.

Why this matters in the New England  Compounding Pharmacy litigation: Access, production, and preparation all will be analyzed to determine if this tragedy could have been prevented if the clean room was operated the right way. 

Talk to our law firm if you were harmed by a medication made by NECC.